361 related articles for article (PubMed ID: 23590310)
41. BMPRII influences the response of pulmonary microvascular endothelial cells to inflammatory mediators.
Vengethasamy L; Hautefort A; Tielemans B; Belge C; Perros F; Verleden S; Fadel E; Van Raemdonck D; Delcroix M; Quarck R
Pflugers Arch; 2016 Nov; 468(11-12):1969-1983. PubMed ID: 27816994
[TBL] [Abstract][Full Text] [Related]
42. 4PBA Restores Signaling of a Cysteine-substituted Mutant BMPR2 Receptor Found in Patients with Pulmonary Arterial Hypertension.
Dunmore BJ; Yang X; Crosby A; Moore S; Long L; Huang C; Southwood M; Austin ED; Rana A; Upton PD; Morrell NW
Am J Respir Cell Mol Biol; 2020 Aug; 63(2):160-171. PubMed ID: 32255665
[TBL] [Abstract][Full Text] [Related]
43. Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension.
Hong KH; Lee YJ; Lee E; Park SO; Han C; Beppu H; Li E; Raizada MK; Bloch KD; Oh SP
Circulation; 2008 Aug; 118(7):722-30. PubMed ID: 18663089
[TBL] [Abstract][Full Text] [Related]
44. Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice.
Long L; MacLean MR; Jeffery TK; Morecroft I; Yang X; Rudarakanchana N; Southwood M; James V; Trembath RC; Morrell NW
Circ Res; 2006 Mar; 98(6):818-27. PubMed ID: 16497988
[TBL] [Abstract][Full Text] [Related]
45. BMPR-II deficiency elicits pro-proliferative and anti-apoptotic responses through the activation of TGFβ-TAK1-MAPK pathways in PAH.
Nasim MT; Ogo T; Chowdhury HM; Zhao L; Chen CN; Rhodes C; Trembath RC
Hum Mol Genet; 2012 Jun; 21(11):2548-58. PubMed ID: 22388934
[TBL] [Abstract][Full Text] [Related]
46. Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice.
Song Y; Coleman L; Shi J; Beppu H; Sato K; Walsh K; Loscalzo J; Zhang YY
Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H677-90. PubMed ID: 18552156
[TBL] [Abstract][Full Text] [Related]
47. TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling.
Hurst LA; Dunmore BJ; Long L; Crosby A; Al-Lamki R; Deighton J; Southwood M; Yang X; Nikolic MZ; Herrera B; Inman GJ; Bradley JR; Rana AA; Upton PD; Morrell NW
Nat Commun; 2017 Jan; 8():14079. PubMed ID: 28084316
[TBL] [Abstract][Full Text] [Related]
48. Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension.
Takahashi H; Goto N; Kojima Y; Tsuda Y; Morio Y; Muramatsu M; Fukuchi Y
Am J Physiol Lung Cell Mol Physiol; 2006 Mar; 290(3):L450-8. PubMed ID: 16361357
[TBL] [Abstract][Full Text] [Related]
49. Rescuing the BMPR2 signaling axis in pulmonary arterial hypertension.
West J; Austin E; Fessel JP; Loyd J; Hamid R
Drug Discov Today; 2014 Aug; 19(8):1241-5. PubMed ID: 24794464
[TBL] [Abstract][Full Text] [Related]
50. Downregulation of bone morphogenetic protein receptor axis during HIV-1 and cocaine-mediated pulmonary smooth muscle hyperplasia: implications for HIV-related pulmonary arterial hypertension.
Dalvi P; O'Brien-Ladner A; Dhillon NK
Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2585-95. PubMed ID: 24008158
[TBL] [Abstract][Full Text] [Related]
51. Bone morphogenetic protein receptor type II C-terminus interacts with c-Src: implication for a role in pulmonary arterial hypertension.
Wong WK; Knowles JA; Morse JH
Am J Respir Cell Mol Biol; 2005 Nov; 33(5):438-46. PubMed ID: 16002577
[TBL] [Abstract][Full Text] [Related]
52. Enhancement of premature stop codon readthrough in the CFTR gene by Ataluren (PTC124) derivatives.
Pibiri I; Lentini L; Melfi R; Gallucci G; Pace A; Spinello A; Barone G; Di Leonardo A
Eur J Med Chem; 2015 Aug; 101():236-44. PubMed ID: 26142488
[TBL] [Abstract][Full Text] [Related]
53. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
[TBL] [Abstract][Full Text] [Related]
54. Endothelial
Theilmann AL; Hawke LG; Hilton LR; Whitford MKM; Cole DV; Mackeil JL; Dunham-Snary KJ; Mewburn J; James PD; Maurice DH; Archer SL; Ormiston ML
Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2605-2618. PubMed ID: 32998516
[TBL] [Abstract][Full Text] [Related]
55. Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension.
Paulin R; Meloche J; Jacob MH; Bisserier M; Courboulin A; Bonnet S
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1798-809. PubMed ID: 21890685
[TBL] [Abstract][Full Text] [Related]
56. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
[TBL] [Abstract][Full Text] [Related]
57. BMPR2 Loss Activates AKT by Disrupting DLL4/NOTCH1 and PPARγ Signaling in Pulmonary Arterial Hypertension.
Awad KS; Wang S; Dougherty EJ; Keshavarz A; Demirkale CY; Yu ZX; Miller L; Elinoff JM; Danner RL
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791441
[TBL] [Abstract][Full Text] [Related]
58. Defective cellular trafficking of the bone morphogenetic protein receptor type II by mutations underlying familial pulmonary arterial hypertension.
John A; Kizhakkedath P; Al-Gazali L; Ali BR
Gene; 2015 Apr; 561(1):148-56. PubMed ID: 25688877
[TBL] [Abstract][Full Text] [Related]
59. The transforming growth factor-β-bone morphogenetic protein type signalling pathway in pulmonary vascular homeostasis and disease.
Upton PD; Morrell NW
Exp Physiol; 2013 Aug; 98(8):1262-6. PubMed ID: 23645549
[TBL] [Abstract][Full Text] [Related]
60. Bone morphogenetic protein signaling in vascular disease: anti-inflammatory action through myocardin-related transcription factor A.
Wang D; Prakash J; Nguyen P; Davis-Dusenbery BN; Hill NS; Layne MD; Hata A; Lagna G
J Biol Chem; 2012 Aug; 287(33):28067-77. PubMed ID: 22718766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
